112 related articles for article (PubMed ID: 16326407)
1. Evaluation of bone mineral density at different phases of therapy of childhood all.
Maniadaki I; Stiakaki E; Germanakis I; Kalmanti M
Pediatr Hematol Oncol; 2006; 23(1):11-8. PubMed ID: 16326407
[TBL] [Abstract][Full Text] [Related]
2. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
[TBL] [Abstract][Full Text] [Related]
4. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
[TBL] [Abstract][Full Text] [Related]
5. Total body bone measurements: a cross-sectional study in children with acute lymphoblastic leukemia during and following completion of therapy.
Kelly KM; Thornton JC; Hughes D; Osunkwo I; Weiner M; Wang J; Horlick M
Pediatr Blood Cancer; 2009 Jan; 52(1):33-8. PubMed ID: 18816694
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of bone metabolism in children with acute lymphoblastic leukemia after induction chemotherapy treatment.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Koliouskas D; Papastergiou C; Tsituridis I
Pediatr Hematol Oncol; 2005 Jun; 22(4):285-9. PubMed ID: 16020115
[TBL] [Abstract][Full Text] [Related]
7. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
[TBL] [Abstract][Full Text] [Related]
8. Is the treatment for childhood solid tumors associated with lower bone mass than that for leukemia and Hodgkin disease?
Muszynska-Roslan K; Konstantynowicz J; Panasiuk A; Krawczuk-Rybak M
Pediatr Hematol Oncol; 2009 Jan; 26(1):36-47. PubMed ID: 19206007
[TBL] [Abstract][Full Text] [Related]
9. Skeletal morbidity in childhood acute lymphoblastic leukemia.
Mandel K; Atkinson S; Barr RD; Pencharz P
J Clin Oncol; 2004 Apr; 22(7):1215-21. PubMed ID: 15051768
[TBL] [Abstract][Full Text] [Related]
10. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.
van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
J Pediatr; 2002 Aug; 141(2):204-10. PubMed ID: 12183715
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density in long-term survivors of childhood cancer.
Hesseling PB; Hough SF; Nel ED; van Riet FA; Beneke T; Wessels G
Int J Cancer Suppl; 1998; 11():44-7. PubMed ID: 9876477
[TBL] [Abstract][Full Text] [Related]
12. [Bone mineral density in children before and after completion of cancer treatment].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M; Kaczmarski M; Piotrowska-Jastrzebska J
Pol Merkur Lekarski; 2004 Jul; 17(97):37-42. PubMed ID: 15559608
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia.
Hartman A; te Winkel ML; van Beek RD; de Muinck Keizer-Schrama SM; Kemper HC; Hop WC; van den Heuvel-Eibrink MM; Pieters R
Pediatr Blood Cancer; 2009 Jul; 53(1):64-71. PubMed ID: 19283791
[TBL] [Abstract][Full Text] [Related]
14. Hypomagnesemia associated with chemotherapy in patients treated for acute lymphoblastic leukemia: possible mechanisms.
Guo CY; Halton JM; Barr RD; Atkinson SA
Oncol Rep; 2004 Jan; 11(1):185-9. PubMed ID: 14654924
[TBL] [Abstract][Full Text] [Related]
15. Little evidence of low bone mass in acute lymphoblastic leukemia survivors.
Muszynska-Roslan K; Panasiuk A; Latoch E; Krawczuk-Rybak M; Konstantynowicz J
J Clin Densitom; 2012; 15(1):108-15. PubMed ID: 21880524
[TBL] [Abstract][Full Text] [Related]
16. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
Wiernikowski JT; Barr RD; Webber C; Guo CY; Wright M; Atkinson SA
J Oncol Pharm Pract; 2005 Jun; 11(2):51-6. PubMed ID: 16460605
[TBL] [Abstract][Full Text] [Related]
17. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia.
Gunes AM; Can E; Saglam H; Ilçöl YO; Baytan B
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e102-7. PubMed ID: 20216235
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
Gonc EN; Kandemir N
Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
[TBL] [Abstract][Full Text] [Related]
19. Predictors of bony morbidity in children with acute lymphoblastic leukemia.
Rayar MS; Nayiager T; Webber CE; Barr RD; Athale UH
Pediatr Blood Cancer; 2012 Jul; 59(1):77-82. PubMed ID: 22190454
[TBL] [Abstract][Full Text] [Related]
20. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Tillmann V; Darlington AS; Eiser C; Bishop NJ; Davies HA
J Bone Miner Res; 2002 Jun; 17(6):1073-80. PubMed ID: 12054163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]